PMID- 35309227 OWN - NLM STAT- MEDLINE DCOM- 20220428 LR - 20220428 IS - 2296-2565 (Electronic) IS - 2296-2565 (Linking) VI - 10 DP - 2022 TI - Prediction of Atrial Fibrillation in Hospitalized Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Mellitus Using Machine Learning: A Multicenter Retrospective Study. PG - 842104 LID - 10.3389/fpubh.2022.842104 [doi] LID - 842104 AB - BACKGROUND: The objective of this study was to use machine learning algorithms to construct predictive models for atrial fibrillation (AF) in elderly patients with coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). METHODS: The diagnosis and treatment data of elderly patients with CHD and T2DM, who were treated in four tertiary hospitals in Chongqing, China from 2015 to 2021, were collected. Five machine learning algorithms: logistic regression, logistic regression+least absolute shrinkage and selection operator, classified regression tree (CART), random forest (RF) and extreme gradient lifting (XGBoost) were used to construct the prediction models. The area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy were used as the comparison measures between different models. RESULTS: A total of 3,858 elderly patients with CHD and T2DM were included. In the internal validation cohort, XGBoost had the highest AUC (0.743) and sensitivity (0.833), and RF had the highest specificity (0.753) and accuracy (0.735). In the external verification, RF had the highest AUC (0.726) and sensitivity (0.686), and CART had the highest specificity (0.925) and accuracy (0.841). Total bilirubin, triglycerides and uric acid were the three most important predictors of AF. CONCLUSION: The risk prediction models of AF in elderly patients with CHD and T2DM based on machine learning algorithms had high diagnostic value. The prediction models constructed by RF and XGBoost were more effective. The results of this study can provide reference for the clinical prevention and treatment of AF. CI - Copyright (c) 2022 Xu, Peng, Tan, Zhao, Yang and Tian. FAU - Xu, Qian AU - Xu Q AD - College of Medical Informatics, Chongqing Medical University, Chongqing, China. AD - Medical Data Science Academy, Chongqing Medical University, Chongqing, China. AD - Collection Development Department of Library, Chongqing Medical University, Chongqing, China. FAU - Peng, Yan AU - Peng Y AD - Department of Cardiology, University-Town Hospital of Chongqing Medical University, Chongqing, China. FAU - Tan, Juntao AU - Tan J AD - Operation Management Office, Affiliated Banan Hospital of Chongqing Medical University, Chongqing, China. FAU - Zhao, Wenlong AU - Zhao W AD - College of Medical Informatics, Chongqing Medical University, Chongqing, China. AD - Medical Data Science Academy, Chongqing Medical University, Chongqing, China. FAU - Yang, Meijie AU - Yang M AD - College of Medical Informatics, Chongqing Medical University, Chongqing, China. FAU - Tian, Jie AU - Tian J AD - Medical Data Science Academy, Chongqing Medical University, Chongqing, China. AD - Department of Cardiology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China. AD - Chongqing Key Laboratory of Pediatrics, Chongqing, China. LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20220304 PL - Switzerland TA - Front Public Health JT - Frontiers in public health JID - 101616579 SB - IM MH - Aged MH - *Atrial Fibrillation/diagnosis MH - *Coronary Disease/epidemiology MH - *Diabetes Mellitus, Type 2/complications MH - Humans MH - Machine Learning MH - Retrospective Studies PMC - PMC8931193 OTO - NOTNLM OT - atrial fibrillation OT - coronary heart disease OT - machine learning OT - prediction models OT - type 2 diabetes mellitus COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/03/22 06:00 MHDA- 2022/04/29 06:00 PMCR- 2022/03/04 CRDT- 2022/03/21 08:48 PHST- 2021/12/23 00:00 [received] PHST- 2022/02/09 00:00 [accepted] PHST- 2022/03/21 08:48 [entrez] PHST- 2022/03/22 06:00 [pubmed] PHST- 2022/04/29 06:00 [medline] PHST- 2022/03/04 00:00 [pmc-release] AID - 10.3389/fpubh.2022.842104 [doi] PST - epublish SO - Front Public Health. 2022 Mar 4;10:842104. doi: 10.3389/fpubh.2022.842104. eCollection 2022.